HomeCompareCGECF vs MRK

CGECF vs MRK: Dividend Comparison 2026

CGECF yields 5.51% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CGECF wins by $2327.62M in total portfolio value
10 years
CGECF
CGECF
● Live price
5.51%
Share price
$50.21
Annual div
$2.77
5Y div CAGR
92.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2327.68M
Annual income
$2,214,501,908.21
Full CGECF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CGECF vs MRK

📍 CGECF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGECFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGECF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGECF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGECF
Annual income on $10K today (after 15% tax)
$468.25/yr
After 10yr DRIP, annual income (after tax)
$1,882,326,621.98/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CGECF beats the other by $1,882,318,293.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGECF + MRK for your $10,000?

CGECF: 50%MRK: 50%
100% MRK50/50100% CGECF
Portfolio after 10yr
$1163.87M
Annual income
$1,107,255,853.18/yr
Blended yield
95.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CGECF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
0.7
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGECF buys
0
MRK buys
0
No recent congressional trades found for CGECF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGECFMRK
Forward yield5.51%2.76%
Annual dividend / share$2.77$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR92.5%32.7%
Portfolio after 10y$2327.68M$56.8K
Annual income after 10y$2,214,501,908.21$9,798.13
Total dividends collected$2319.57M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CGECF vs MRK ($10,000, DRIP)

YearCGECF PortfolioCGECF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,760$1,060.45$11,206$366.19+$554.00CGECF
2$14,827$2,243.68$12,650$502.35+$2.2KCGECF
3$20,954$5,089.17$14,407$694.19+$6.5KCGECF
4$35,360$12,939.17$16,585$967.82+$18.8KCGECF
5$77,118$39,282.12$19,342$1,363.89+$57.8KCGECF
6$236,643$154,127.05$22,913$1,947.19+$213.7KCGECF
7$1,104,082$850,873.66$27,662$2,823.89+$1.08MCGECF
8$8,323,361$7,141,993.84$34,159$4,173.35+$8.29MCGECF
9$105,770,341$96,864,344.63$43,337$6,308.80+$105.73MCGECF
10$2,327,676,173$2,214,501,908.21$56,776$9,798.13+$2327.62MCGECF

CGECF vs MRK: Complete Analysis 2026

CGECFStock

Cogeco Inc., through its subsidiaries, operates in the communications and media sectors in Canada and the United States. The company operates in two segments, Communications and Other. The Communications segment provides a range of Internet, video, and telephony services through its two-way broadband fiber networks primarily to residential customers, as well as to small and medium sized businesses under the Cogeco Connexion name in Quebec and Ontario; and Atlantic Broadband brand in the United States. The Other segment owns and operates 23 radio stations with complementary radio formats and coverage serving a range of audiences primarily across the province of Québec; and Cogeco News, a news agency. It serves primary service units, Internet, video, and telephony service customers. The company was incorporated in 1957 and is headquartered in Montreal, Canada.

Full CGECF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CGECF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGECF vs SCHDCGECF vs JEPICGECF vs OCGECF vs KOCGECF vs MAINCGECF vs JNJCGECF vs ABBVCGECF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.